Icon-testtube Copy Created with Sketch.

Emerging Infectious Disease

MRIGlobal’s emerging infectious disease services span all stages of the diagnostic product development process, beginning with research and development through product clearance and launch.

Our infectious disease diagnostics R&D and IVD product development capabilities include, but are not limited to:

  • Development of methods, platforms, and molecular and immunological assays
  • Turnkey, outsourcing solutions for commercial and government clients
  • Accelerated product development through analytical verification and clinical validation phases 

Our Staff

Kyle Parker inspects a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.

MRIGlobal scientists conduct research and development with commercial companies to improve emerging infectious disease diagnostic technologies with the goal of advancing these technologies into verification and validation phases of clinical product development.

Photo of Kyle Parker inspecting a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.

Work with us

MRIGlobal looks forward to contributing our expertise where it matters most.

Use our Project Quote Tool to learn more about how we can help with your next endeavor.

Project Quote Tool

See Our Certifications

See Our Facilities